https://pubmed.ncbi.nlm.nih.gov/38113165

The combination of partial normoxic recovery and senolytic therapy with Navitoclax in a mouse model of obstructive sleep apnea improved sleepiness, cognition, coronary artery function, and metabolism, as well as reduced intestinal permeability and senescence in multiple organs, suggesting that end-organ morbidities induced by sleep apnea can be reversed through targeting other detrimental cellular processes.